The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy
- 1 November 2000
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 153 (1) , 89-98
- https://doi.org/10.1016/s0021-9150(00)00373-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Plasmapheresis for Prevention and Regression of Coronary AtherosclerosisAnnals of the New York Academy of Sciences, 2006
- Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemiaAmerican Heart Journal, 1999
- The Retardation of Progression, Stabilization, and Regression of Coronary and Carotid Atherosclerosis by Low-Density Lipoprotein Apheresis in Patients with Familial HypercholesterolemiaTherapeutic Apheresis, 1997
- Apheresis Technology for Prevention and Regression of Atherosclerosis: An OverviewTherapeutic Apheresis, 1997
- LDL-Apheresis Atherosclerosis Regression Study (LAARS)Circulation, 1996
- Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemiaNature Genetics, 1994
- How effective is drug therapy in heterozygous familial hypercholesterolemia?The American Journal of Cardiology, 1993
- Regression of carotid plaques during low density lipoprotein cholesterol elimination.Stroke, 1991
- Liver transplantation for treatment of cardiovascular disease: Comparison with medication and plasma exchange in homozygous familial hypercholesterolemiaThe American Journal of Cardiology, 1987
- LDL-apheresis. Potential procedure for prevention and regression of atheromatous vascular lesion.Japanese Circulation Journal, 1987